We Are JPEO

The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) manages our nation’s investments in chemical, biological, radiological, and nuclear (CBRN) defense equipment and medical countermeasures.

The JPEO-CBRND leads, manages, and directs the acquisition, fielding and sustainment of CBRN sensors, protective equipment, medical countermeasures, information management systems, defense enabling biotechnologies, and specialized equipment for U.S. Special Forces. The organization also works closely with various government agencies that need CBRN defense equipment. Learn more about the Joint Project Management Offices for CBRN Protection, CBRN Medical, and CBRN Sensors.

Learn more about the JPEO-CBRND

Our Mission

Protect the Joint Force from weapons of mass destruction by generating affordable capabilities.

Our Vision

A resilient Joint Force enabled to fight and win unencumbered by a chemical, biological, radiological, or nuclear environment; championed by innovative, agile, results-oriented acquisition professionals.

Partnering Benefits

 

Work with the JPEO-CBRND on providing solutions that protect the Joint Force and the Warfighter from weapons of mass destruction. Help us achieve our vision of a resilient Joint Force that's enabled to fight and win unencumbered by CBRN environments.

Innovative Contracting Experience iconInnovative Contracting Experience

Our Other Transactional Authority (OTA) agreements enable enhanced communications and support innovation. 

Agile Execution iconAgile Execution

We face a complex threat environment, so we need the partnership and support of industry and academia to help us innovate at the speed of relevancy for our current CBRN defense environments.

Share iconShare Your Latest Insights with Government

The JPEO-CBRND is eager to learn more about the latest innovations, capabilities and insights to help support the Joint Force and protect our Warfighters. 

Keep Current iconKeep Current on the CBRND Industrial Base’s Needs

Gain insight into the way ahead for our organization as well as our CBRND partners.

Modernize iconHelp Modernize the Joint Force 

Help establish and refine the long-term vision for CBRND capabilities.

Speed iconDevelopment at the Speed of Relevancy

Help the JPEO-CBRND tackle the R&D needs on the horizon and learn more about our “new start” programs here.

Featured Technologies

Joint Service General Purpose Mask (JSGPM)

Joint Service General Purpose Mask (JSGPM)

LEARN MORE

Next Generation Diagnostics System 1 (NGDS 1)

Next Generation Diagnostics System 1 (NGDS 1)

LEARN MORE

Nuclear, Biological, Chemical Reconnaissance Vehicle

Nuclear, Biological, Chemical Reconnaissance Vehicle (NBCRV)

LEARN MORE

News

Two lab technicians dress in PPE

JPEO-CBRND, JPM CBRN Medical Leads DOD Ebola Outbreak Response Efforts

News
Apr. 28, 2021

DISCLAIMER: Included references to commercial products does not constitute endorsement by the U.S. Department...
Read More
Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

SAB Biotherapeutics Doses First Patient with SAB-185 for the Treatment of COVID-19 in NIH’s ACTIV-2 Phase 2/3 Clinical Trial

News
Apr. 21, 2021

https://finance.yahoo.com/news/sab-biotherapeutics-doses-first-patient-200200245.html
Read More
Two masked women service members are in the photo. One servicemember is giving the other a COVID-19 vaccination in her upper arm.

JPEO-CBRND Investment Initiates Phase II Clinical Trial Using Tafenoquine to Treat COVID-19

News
Mar. 12, 2021

FOR IMMEDIATE RELEASE - The JPM CBRN Medical executed an agreement with 60P to study the effectiveness of an...
Read More
Two uniformed service members are in a tent. One wears PPE and a faceshield, while they use a nasal swab to collect a COVID-19 sample from the other Service member in uniform.

SARPAC Clinical Trial of Leukine® (sargramostim, rhu GM-CSF) in Hospitalized COVID-19 Patients Meets Primary Endpoint of Significant Improvement in Lung Function

News
Feb. 26, 2021

Link to full article...
Read More
COVID-19 vaccine rollout ongoing in U.S. Army Central footprint

Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna

News
Feb. 12, 2021

FOR IMMEDIATE RELEASE - The U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD)...
Read More
Compassionate care nurses

DOD Awards Industry Partner Immunome $13.3 Million for Biosynthetic Convalescent Plasma Development

News
Feb. 11, 2021

The JPM CBRN Medical leveraged an industry partnership to accelerate COVID-19 prevention and treatment...
Read More
Army Pfc. Christopher Elsberry, assigned to the 36th Medical Company Area Support Battalion, sanitizes a chair inside the mobile COVID-19 testing unit at the Javits Center in New York City, May 19, 2020.

DOD Supports Phase III Clinical Trial Using Fostamatinib (TAVALISSE®) Against COVID-19

News
Jan. 29, 2021

The JPM CBRN Medical executed an agreement with Rigel Pharmaceuticals, Inc., to study the effectiveness of...
Read More
h

DOD Supports Phase II Clinical Trials Repurposing Inhaled PUL-042 for COVID-19 Prevention and Treatment

News
Jan. 26, 2021

The JPM CBRN Medical executed an agreement with Pulmotect, Inc. to study the effectiveness of an existing...
Read More
Remdesivir drug in syringe

Broad-spectrum antiviral proves safe and effective against COVID-19

News
Dec. 01, 2020

Yesterday, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences, Inc.’s Veklury® (Remdesivir)...
Read More

Where to Find Us

National Defense Industrial Association (NDIA) CBRN Defense Conference
May 3, 2021 - August 16–18, 2021Responding Now – Preparing for Future CBRN Threats.Baltimore, MD (In Person)Learn More

CBRNe Convergence 2021
May 3, 2021 - November 2, 2021Annual conference and exhibition hosted by CBRNe World.Orlando, FL (In Person)Learn More

CBRNe Summit USA
May 3, 2021 - October 12-14, 2021Gathering of military and civil officials who deal with CBRNe incidents. Las Vegas, NVLearn More 

NCT Europe
May 3, 2021 - October 5-7, 2021Connecting the European CBRNe Community.Rieti, Italy (In Person & Virtual)Learn More

Chemical Corps Regimental Association CBRN Exhibition, Fort Leonard Wood
May 3, 2021 - June 22–23, 2021A gathering of CBRN / WMD Joint, Multinational, Industry and CBRN Professionals. Fort Leonard Wood, MO (In Person)Learn more

18th Airborne Corps CBRNE Regimental Week
May 3, 2021 - June 1–4, 2021Meet with CBRNE Soldiers serving throughout the force and bring them together for teaching, mentorship, and awareness while promoting the CBRNE career fields and the opportunities available to them. Fort Bragg,...

Special Operations Medical Scientific Assembly (SOMA) Conference
May 3, 2021 - June 28–July 02, 2021Connecting military and civilian medical providers, academia and industry partners from around the world. Charlotte Convention Center, Charlotte, NC (In Person)Learn More

SPARK FY22 Virtual Kick-Off Event
April 27, 2021 - Event Date TBD  ​JPEO-CBRND's Idea Incubator will host a live event in early June. This live event will help share more details about the SPARK FY22 incubator process and how to submit a proposal. Stay tuned for more details...

BIO Digital 2021
April 23, 2021 - June 10-18, 2021BIO Digital is the world's largest virtual biotech partnering and education event, convening thousands of global biotech leaders and innovators. Join us in our efforts to inspire a bio-revolution through...
The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. Government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.